Jci_page_head_homepage_01 Jci_page_head_homepage_02
Nichole R. Klatt, Francois Villinger, Pavel Bostik, Shari N. Gordon, Lara Pereira, Jessica C. Engram, Ann Mayne, Richard M. Dunham, Benton Lawson, Sarah J. Ratcliffe, Donald L. Sodora, James Else, Keith Reimann, Silvija I. Staprans, Ashley T. Haase, Jacob D. Estes, Guido Silvestri, Aftab A. Ansari
Published in Volume 118, Issue 6
J Clin Invest. 2008; 118(6):2039–2049 doi:10.1172/JCI33814
Abstract | Full text | PDF | Supplemental material
Options: View larger image (or click on image)
Medium
Figure 3
CD4+ T cell depletion is associated with a decline of viremia in SIV-infected SMs.

(A) Longitudinal assessment of SIV plasma viral load (SIV copies/ml plasma by RT-PCR) for each animal through 240 d after depletion. Dotted lines and tick marks represent CD4-depleting antibody treatment. (B and C) In situ hybridization demonstrated SIV RNA+ productively infected cells were uniformly located within the T cell zone of LNs both prior to CD4+ T cell depletion (–30 d) and following the reemergence of CD4+ T cells after treatment (60 and 120 d), but were absent concurrent to loss of plasma viremia (14 d).